Can you tell me where management went wrong by achieving an 8-fold+ improvement in treatment outcomes for Black and African American covid patients? How did they fail in LIVE-AIR by achieving Hazard Ratios of between 2.5 - 3.4?
The CMML and aGvHD studies also used lenz, and we know that data is positive. I hope it results in regulatory approvals from the UK and Australia. Is that because management failed?
The attempted sabotage of our LIVE-AIR trial results by using sicker patients in the ACTIV-5 trial, even those on IMV, still showed improved treatment outcomes, comparable to the outcome achieved by Gohibic, for which they were given an EUA. Is that failed management?
Why is it so hard for you to understand that the reason we have lost $1.3B in market cap is because we threaten the $38B in covid revenue Pfizer is realizing?
The stark reality is, if this corruption is permitted to continue, our ICU's will be too overwhelmed and under-resourced to effectively save us. Stateside Chinese-owned biotech with bio-engineered mice to catch and carry covid? ICU utilization already increasing?
Direct your anger to where it rightly belongs, against the agencies charged with approving this life-saving therapeutic.
News 
Market Data 
Discover 
